FRASER & COMPANY | REMUS PHARMA | FRASER & COMPANY/ REMUS PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -17.1 | - | - | View Chart |
P/BV | x | 0.5 | 55.6 | 0.9% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
FRASER & COMPANY REMUS PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
FRASER & COMPANY Mar-23 |
REMUS PHARMA Mar-23 |
FRASER & COMPANY/ REMUS PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 11 | NA | - | |
Low | Rs | 6 | NA | - | |
Sales per share (Unadj.) | Rs | 12.9 | 413.1 | 3.1% | |
Earnings per share (Unadj.) | Rs | 0.4 | 78.0 | 0.5% | |
Cash flow per share (Unadj.) | Rs | 0.6 | 82.4 | 0.7% | |
Dividends per share (Unadj.) | Rs | 0 | 2.00 | 0.0% | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 9.8 | 175.6 | 5.6% | |
Shares outstanding (eoy) | m | 8.12 | 1.09 | 745.0% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.6 | 0 | - | |
Avg P/E ratio | x | 19.3 | 0 | - | |
P/CF ratio (eoy) | x | 14.3 | 0 | - | |
Price / Book Value ratio | x | 0.8 | 0 | - | |
Dividend payout | % | 0 | 2.6 | 0.0% | |
Avg Mkt Cap | Rs m | 66 | 0 | - | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2 | 55 | 3.5% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 105 | 450 | 23.3% | |
Other income | Rs m | 0 | 16 | 0.1% | |
Total revenues | Rs m | 105 | 466 | 22.6% | |
Gross profit | Rs m | 7 | 105 | 6.2% | |
Depreciation | Rs m | 1 | 5 | 25.2% | |
Interest | Rs m | 1 | 2 | 33.0% | |
Profit before tax | Rs m | 5 | 114 | 4.1% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 1 | 29 | 4.2% | |
Profit after tax | Rs m | 3 | 85 | 4.0% | |
Gross profit margin | % | 6.3 | 23.4 | 26.8% | |
Effective tax rate | % | 26.3 | 25.5 | 103.2% | |
Net profit margin | % | 3.3 | 18.9 | 17.2% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 114 | 113 | 100.3% | |
Current liabilities | Rs m | 41 | 82 | 49.9% | |
Net working cap to sales | % | 69.5 | 7.1 | 983.7% | |
Current ratio | x | 2.8 | 1.4 | 200.9% | |
Inventory Days | Days | 64 | 167 | 38.4% | |
Debtors Days | Days | 366,539,249 | 393 | 93,274,922.7% | |
Net fixed assets | Rs m | 21 | 232 | 9.2% | |
Share capital | Rs m | 81 | 11 | 748.4% | |
"Free" reserves | Rs m | -1 | 181 | -0.7% | |
Net worth | Rs m | 80 | 191 | 41.8% | |
Long term debt | Rs m | 3 | 71 | 4.2% | |
Total assets | Rs m | 135 | 345 | 39.1% | |
Interest coverage | x | 7.0 | 50.0 | 14.1% | |
Debt to equity ratio | x | 0 | 0.4 | 10.2% | |
Sales to assets ratio | x | 0.8 | 1.3 | 59.6% | |
Return on assets | % | 3.1 | 25.3 | 12.3% | |
Return on equity | % | 4.3 | 44.4 | 9.6% | |
Return on capital | % | 6.5 | 44.4 | 14.7% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 1.1 | 0.0% | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | 5 | 0.0% | |
Fx inflow | Rs m | 0 | 440 | 0.0% | |
Fx outflow | Rs m | 0 | 18 | 0.0% | |
Net fx | Rs m | 0 | 422 | 0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2 | 53 | 4.3% | |
From Investments | Rs m | -7 | -152 | 4.6% | |
From Financial Activity | Rs m | NA | 118 | 0.1% | |
Net Cashflow | Rs m | -5 | 19 | -24.8% |
Indian Promoters | % | 3.1 | 70.6 | 4.4% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 3.9 | 0.3% | |
FIIs | % | 0.0 | 3.3 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 96.9 | 29.4 | 329.5% | |
Shareholders | 6,193 | 1,124 | 551.0% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare FRASER & COMPANY With: ADANI ENTERPRISES REDINGTON MMTC SIRCA PAINTS INDIA NOVARTIS
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | FRASER & COMPANY | REMUS PHARMA |
---|---|---|
1-Day | 1.19% | -7.80% |
1-Month | 4.49% | 5.10% |
1-Year | -3.76% | 125.49% |
3-Year CAGR | -3.23% | 31.13% |
5-Year CAGR | -10.73% | 17.66% |
* Compound Annual Growth Rate
Here are more details on the FRASER & COMPANY share price and the REMUS PHARMA share price.
Moving on to shareholding structures...
The promoters of FRASER & COMPANY hold a 3.1% stake in the company. In case of REMUS PHARMA the stake stands at 70.6%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of FRASER & COMPANY and the shareholding pattern of REMUS PHARMA.
Finally, a word on dividends...
In the most recent financial year, FRASER & COMPANY paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
REMUS PHARMA paid Rs 2.0, and its dividend payout ratio stood at 2.6%.
You may visit here to review the dividend history of FRASER & COMPANY, and the dividend history of REMUS PHARMA.
After opening the day on positive note, Indian share markets continued the momentum as the session progressed and ended on firm footing.